[Gender Aspects in Angioedema]

Overview

Journal Hautarzt

Specialty Dermatology

Date 2019 Jan 11

PMID 30627747

Citations 1

Authors

G Bindke

K Schorling

D Wieczorek

A Kapp

B Wedi

Affiliations

Soon will be listed here.

Abstract

Background: Angioedema can be triggered by mediators bradykinin or histamine. Gender-specific differences and potential biomarkers for follow-up/therapy monitoring are mostly unknown.

Objectives: To what extent are gender-related defects, prodromes, trigger factors, clinical parameters such as number of attacks, frequency, localization, laboratory values, hormones and response to therapy different for the variant types of angioedema.

Materials And Methods: A literature search was performed in PubMed with the keywords "angioedema" and "sex" or "gender" as well as targeted screening of reviews, guidelines and registration studies with angioedema-relevant drugs.

Results: In histamine-mediated angioedema, there are few gender-specific differences. In bradykinin-mediated hereditary angioedema, especially with factor XII mutation, but also in angiotensin-converting enzyme inhibitor-induced angioedema, women are more frequent, more affected and hormonal influences are documented. The localization of bradykinin-mediated hereditary angioedema (HAE) is also gender specific. The proportion of women in clinical trials for HAE therapies is about two-thirds.

Conclusion: Principally, differentiating between estrogen-dependent, estrogen-sensitive and estrogen-insensitive angioedema seems reasonable. The characterization of these subgroups may lead to a better understanding of the pathomechanism of the hormone effects on angioedema. This could lead to the development of urgently needed biomarkers for faster and more targeted diagnosis and prediction of attacks, to significantly improve the health and quality of life of angioedema patients by means of individualized gender-specific therapy.

Citing Articles

Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports.

Dubrall D, Schmid M, Stingl J, Sachs B PLoS One. 2020; 15(3):e0230632.

PMID: 32214375 PMC: 7098604. DOI: 10.1371/journal.pone.0230632.

References

Bork K, Barnstedt S, Koch P, Traupe H . Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000; 356(9225):213-7. DOI: 10.1016/S0140-6736(00)02483-1. View

Bork K, Fischer B, Dewald G . Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med. 2003; 114(4):294-8. DOI: 10.1016/s0002-9343(02)01526-7. View

Visy B, Fust G, Varga L, Szendei G, Takacs E, Karadi I . Sex hormones in hereditary angioneurotic oedema. Clin Endocrinol (Oxf). 2004; 60(4):508-15. DOI: 10.1111/j.1365-2265.2004.02009.x. View

Bas M, Hoffmann T, Bier H, Kojda G . Increased C-reactive protein in ACE-inhibitor-induced angioedema. Br J Clin Pharmacol. 2005; 59(2):233-8. PMC: 1884750. DOI: 10.1111/j.1365-2125.2004.02268.x. View

Bork K, Staubach P, Eckardt A, Hardt J . Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol. 2006; 101(3):619-27. DOI: 10.1111/j.1572-0241.2006.00492.x. View

Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A . Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008; 199(5):484.e1-4. DOI: 10.1016/j.ajog.2008.04.034. View

Bork K, Wulff K, Hardt J, Witzke G, Staubach P . Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J Allergy Clin Immunol. 2009; 124(1):129-34. DOI: 10.1016/j.jaci.2009.03.038. View

Vitrat-Hincky V, Gompel A, Dumestre-Perard C, Boccon-Gibod I, Drouet C, Cesbron J . Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy. 2010; 65(10):1331-6. DOI: 10.1111/j.1398-9995.2010.02368.x. View

Zuraw B, Busse P, White M, Jacobs J, Lumry W, Baker J . Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 2010; 363(6):513-22. DOI: 10.1056/NEJMoa0805538. View

10.

Bork K, Wulff K, Meinke P, Wagner N, Hardt J, Witzke G . A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. Clin Immunol. 2011; 141(1):31-5. DOI: 10.1016/j.clim.2011.07.002. View

11.

Hofman Z, Relan A, Hack C . C-reactive protein levels in hereditary angioedema. Clin Exp Immunol. 2014; 177(1):280-6. PMC: 4089178. DOI: 10.1111/cei.12314. View

12.

Magerl M, Doumoulakis G, Kalkounou I, Weller K, Church M, Kreuz W . Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema. Clin Exp Dermatol. 2014; 39(3):298-303. DOI: 10.1111/ced.12285. View

13.

Zotter Z, Csuka D, Szabo E, Czaller I, Nebenfuhrer Z, Temesszentandrasi G . The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency. Orphanet J Rare Dis. 2014; 9:44. PMC: 3977696. DOI: 10.1186/1750-1172-9-44. View

14.

Stauber T, Confino-Cohen R, Goldberg A . Life-threatening angioedema induced by angiotensin-converting enzyme inhibitors: characteristics and risk factors. Am J Rhinol Allergy. 2014; 28(1):54-8. DOI: 10.2500/ajra.2014.28.3989. View

15.

Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica G . The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014; 69(7):868-87. DOI: 10.1111/all.12313. View

16.

Amsler E, Augey F, Soria A, Boccon-Gibod I, Doutre M, Mathelier-Fusade P . Chronic urticaria and hormones: Is there a link?. J Eur Acad Dermatol Venereol. 2016; 30(9):1527-30. DOI: 10.1111/jdv.13644. View

17.

Steiner U, Weber-Chrysochoou C, Helbling A, Scherer K, Schmid Grendelmeier P, Wuillemin W . Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study. Orphanet J Rare Dis. 2016; 11:43. PMC: 4839073. DOI: 10.1186/s13023-016-0423-1. View

18.

Wu M, Perego F, Zanichelli A, Cicardi M . Angioedema Phenotypes: Disease Expression and Classification. Clin Rev Allergy Immunol. 2016; 51(2):162-9. DOI: 10.1007/s12016-016-8541-z. View

19.

Deroux A, Dumestre-Perard C, Khalil-Mgharbel A, Maignan M, Boccon-Gibod I, Fevre M . BIOBRAD Study: The Search for Biomarkers of Bradykinin-Mediated Angio-Oedema Attacks. Int Arch Allergy Immunol. 2016; 170(2):108-114. DOI: 10.1159/000446959. View

20.

Bork K, Wulff K, Witzke G, Hardt J . Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). Allergy. 2016; 72(2):320-324. DOI: 10.1111/all.13076. View